Lynparza and Senna drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lynparza (olaparib) and Senna (senna). Common drug interactions include metastases to lung among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Lynparza and Senna. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Lynparza?

Lynparza has active ingredients of olaparib. eHealthMe is studying from 12,322 Lynparza users. Check the latest studies of Lynparza.

What is Senna?

Senna has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 37,302 Senna users. Check the latest studies of Senna.

On Jul, 13, 2026

33 people who take Lynparza and Senna together, and have interactions are studied.

What are the common drug interactions of Lynparza and Senna, by gender? *:

female:

Metastases to lung (cancer spreads to lung)
Abdominal discomfort
Anaemia (lack of blood)
Bone pain
Haemoglobin decreased
Blood magnesium decreased
Blood potassium decreased
Breast cancer recurrent
Cancer pain
Cardiac infection (an infection of the heart)

male:

Death
Dysphagia (a condition in which swallowing is difficult or painful)
Dysstasia (difficulty in standing)
Platelet count decreased
Thrombosis (formation of a blood clot inside a blood vessel)

What are the common drug interactions of Lynparza and Senna, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Back pain
Bone pain
Dysgeusia (disorder of the sense of taste)

40-49:

Death
Arthralgia (joint pain)
Atelectasis (partial or complete collapse of the lung)
Back pain
Bone pain
Breast cancer metastatic
Cervical spinal stenosis (narrowing of the spinal canal in the neck)
Diarrhoea
Drug ineffective
Dysphagia (a condition in which swallowing is difficult or painful)

50-59:

Anaemia (lack of blood)
Blood magnesium decreased
Blood potassium decreased
Breast cancer recurrent
Cancer pain
Cardiac infection (an infection of the heart)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
Malignant neoplasm progression (cancer tumour came back)
Metastases to abdominal cavity (cancer spreads to abdominal cavity)

60+:

Anaemia macrocytic (a macrocytic class of anaemia)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Neuropathy peripheral (surface nerve damage)
Rhinorrhoea (watery mucus discharge from the nose)
Weight decreased
White blood cell count increased
Death
Fatigue (feeling of tiredness)
Salivary hypersecretion (excess saliva secretion)
Anxiety

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 20 people, 60.61%
Insomnia (sleeplessness): 7 people, 21.21%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 18.18%
High Blood Cholesterol: 6 people, 18.18%
Stress And Anxiety: 3 people, 9.09%
Blood Glucose Abnormal: 3 people, 9.09%
Blood Pressure Abnormal: 3 people, 9.09%
Bone Pain: 3 people, 9.09%
Sleep Disorder: 3 people, 9.09%
Indigestion: 3 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Lynparza and Senna?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously